August 24, 2014 | Israeli biotechnology company NeuroDerm raised $16 million in investments to continue working on its wearable treatment for Parkinson’s disease. The financing round was led by existing investors. The company is currently in the midst of a mid-stage study for its treatment for neurodegenerative disease, a belt pump that is worn around the waist and continuously administers Parkinson’s drugs for the most severe cases. The company and the testing of their Phase II treatment received a $1 million from the Michael J. Fox Foundation for Parkinson’s Research.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments